Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-19T19:07:52.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Travel-screening documentation to enable the “Identify–Isolate–Inform” framework for emerging infectious diseases: It’s all in the details

Published online by Cambridge University Press:  27 August 2020

Sarimer M. Sánchez Open the ORCID record for Sarimer M. Sánchez [Opens in a new window] ,
Eileen F. Searle ,
David Rubins ,
Sayon Dutta ,
Winston Ware ,
Paul D. Biddinger  and
Erica S. Shenoy
Sarimer M. Sánchez*
Affiliation:
Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
Eileen F. Searle
Affiliation:
Center for Disaster Medicine, Massachusetts General Hospital, Boston, Massachusetts Region 1 Regional Emerging Special Pathogens Treatment Center, Massachusetts
David Rubins
Affiliation:
Brigham & Women’s Hospital, Boston, Massachusetts Mass General Brigham Clinical Informatics
Sayon Dutta
Affiliation:
Mass General Brigham Clinical Informatics Harvard Medical School, Boston, Massachusetts Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts
Winston Ware
Affiliation:
Center for Quality and Safety, Massachusetts General Hospital, Boston, Massachusetts
Paul D. Biddinger
Affiliation:
Center for Disaster Medicine, Massachusetts General Hospital, Boston, Massachusetts Region 1 Regional Emerging Special Pathogens Treatment Center, Massachusetts Harvard Medical School, Boston, Massachusetts Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts
Erica S. Shenoy
Affiliation:
Infection Control Unit, Massachusetts General Hospital, Boston, Massachusetts Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts Region 1 Regional Emerging Special Pathogens Treatment Center, Massachusetts Harvard Medical School, Boston, Massachusetts
*
Author for correspondence: Sarimer M. Sánchez, E-mail: sarimer_sanchez@hms.harvard.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

The early phase of the coronavirus disease 2019 (COVID-19) pandemic and ongoing efforts for mitigation underscore the importance of universal travel and symptom screening. We analyzed adherence to documentation of travel and symptom screening through a travel navigator tool with clinical decision support to identify patients at risk for Middle East Respiratory Syndrome.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 41 , Issue 12 , December 2020 , pp. 1449 - 1451
Check for updates
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: A preliminary analysis of this data was submitted as a Poster Abstract for the Society for Healthcare Epidemiology of America (SHEA) Sixth International Conference on Healthcare Associated Infections and will be published in a supplemental issue of SHEA’s scientific journal, Infection Control and Hospital Epidemiology (ICHE).

References

Morens, DM, Folkers, GK, Fauci, AS. Emerging infections: a perpetual challenge. Lancet Infect Dis 2008;8:710–719.Google ScholarPubMed
Koenig, KL, Beÿ, CK, McDonald, EC. 2019-nCoV: the identify-isolate-inform (3I) tool applied to a novel emerging coronavirus. West J Emerg Med 2020;21:184–190.Google ScholarPubMed
Burkholder, TW, Dziadkowiec, O, Bookman, K, King, RA. Adherence to universal travel screening in the emergency department during epidemic Ebola virus disease. J Emerg Med 2019;56:7–14.CrossRefGoogle ScholarPubMed
Foote, MMK, Styles, TS, Quinn, CL. Assessment of hospital emergency department response to potentially infectious diseases using unannounced mystery patient drills—New York City, 2016. Morb Mortal Wkly Rept 2017;66:945–949.CrossRefGoogle ScholarPubMed